Home›Companies›Healthcare›ALZpath

ALZpath, Inc.

Licenses an antibody to diagnostic companies for use in Alzheimer's blood tests.

Updated Nov 10, 2026·Latest SEC filing Jul 21, 2026·Suggest an edit

About ALZpath

ALZpath is a private company based in Carlsbad, California. It has reported $8,411,219 raised in one offering on Form D since July 2026. Its chief executive is Michael Banville.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 14, 2026Jul 21, 2026$8,411,219of $10.4M target8$1.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ALZpath's Form D filed Jul 21, 2026.

Sources

  1. SECALZpath, Inc. filing history
  2. CompanyPrivacy policy
  3. CompanyAbout ALZpath
  4. PressALZpath board appointment